Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Is It Necessary to Discontinue Metformin in Diabetic Patients With Gfr > 60 Ml/Min Per 1.73 M 2 Undergoing Coronary Angiography: A Controversy Still Exists? Publisher Pubmed



Namazi MH1 ; Parsa SA1 ; Roohigilani K2 ; Safi M1 ; Vakili H1 ; Khaheshi I1 ; Abedi F1 ; Zare A1 ; Esmaeeli S3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cardiovascular Research Center, Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Labbafi-negad Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Student’s Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran

Source: Acta Biomedica Published:2018


Abstract

Background: Although metformin is not directly nephrotoxic, it has been postulated that it can impair gluconeogenesis from lactate, which may lead lactate to be accumulated under circumstances such as contrast-induced nephropathy. The present study aims to assess the role of metformin in lactate production in a group of diabetic patients with GFR > 60 ml/min per 1.73 m 2 undergoing coronary angiography. Methods: In the present randomized clinical trial, 162 metformin-treated diabetic patients were enrolled. The enlisted patients were scheduled to undergo coronary angiography at Modarres Hospital from Feb 2012 to Nov 2012. Patients were randomly allocated to continue metformin during peri-angiography period (M (+) group) or to stop the medication 24 hours prior the procedure (M (-) group). All the patients had glomerular filtration rate of >60 mL/min per 1.73 m 2 . Iodixanol was the only contrast media which in all patients. Metformin-associated lactic acidosis (MALA) was defined as an arterial pH <7.35 and plasma lactate concentration >5 mmol⁄L. Results: 162 patients, including79 (48.7%) male and 83 (51.3%) female patients were enrolled in the study. The average of GFR was comparable in both groups (76 ml/min per 1.73 m 2 in the M (+) group versus 79 ml/min per 1.73 m 2 in the M (-) group, p=0.53). No significant difference was observed in the mean dose of metformin before the study between the 2 groups (2.18 tablets per day in M (+) group vs. 2.21 tablets per day in M(-) group, p=0.62).No lactic acidosis was observed in the studied groups. Conclusion: In conclusion, the results of the present study indicate that metformin continuation in diabetic patients with a GFR of more than 60 ml/min per 1.73 m 2 undergoing coronary angiography does not enhance the risk of MALA development. © Mattioli 1885.
Related Docs
Experts (# of related papers)